Clayton Biotechnologies, Inc. is a for

Report
Overview of Clayton Biotechnologies, Inc.
Clayton Biotechnologies, Inc.
One Riverway, Suite 1520
Houston, Texas 77056
713.963.5860
www.claytonbiotech.com
1
Clayton Biotechnologies, Inc. is a for-profit company which facilitates the
commercialization of medical discoveries made by the Clayton Foundation for
Research and its supporting entities.
The Clayton Foundation for Research is a nonprofit medical research organization in
Houston, Texas established in 1933 by Benjamin Clayton.
The mission of the Foundation is two-fold:
To conduct medical research for the purpose of discovering the cause,
prevention and cure of diseases for the benefit of mankind, and
To transfer the resulting medical research discoveries from the laboratory to
the use of the general public by patenting and licensing such technology for
development into drugs or other products.
2
We conduct and fund medical research programs at leading
universities, hospitals and academic institutions
■
Baylor College of Medicine
■
Baylor College of Medicine Texas Children's Cancer Center
■
North Carolina State University
■
Oregon Health and Science University
■
Salk Institute for Biological Studies
■
The University of Texas at Austin
■
The University of Texas Health Science Center at San Antonio
■
The University of Texas M.D. Anderson Cancer Center
■
The University of Texas Medical Branch at Galveston
■ The University of Texas Southwestern Medical Center at Dallas
■
University of California, San Diego
■
University of Geneva
3
Leading Researchers
ANTIBODIES & ONCOLOGY
CNS & OPHTHAMOLOGY
■ George Georgiou
■ Kuo-Fen Lee
■ Jordan Gutterman
■ Karl-Heinz Krause
■ Stephen Howell
■ Paul Sawchenko
■ Brent Iverson
■ Tim Stout
■ Beat Imhof
■ Bert O’Malley
VIROLOGY and MICROBIOLOGY
■ Donald Parsons
■ Dennis Brown and Raquel Hernandez
■ Michael Rosenblum
■ Jere McBride and David Walker
■ Hongtao Yu
■ Haley Tucker and James Walker
METABOLIC DISEASES
OTHER
■ Marc Montminy
■ Marc Feldman and Thomas Milner
■ David Russell
■ David Corry
4
Some of our start-up companies
5
Some of our Other Licensees
6
Products Brought to the Market
Therapeutics
Diagnostics
SCA6 diagnostic tests
Complete Ataxia Evaluation
AccuPlex™4 test
7
Collaboration and Licensing Opportunities
•Antibody targets for cancer: Grp78; Srpx2, Olmfl-3
•Alk4-Fc, a Cripto antagonist for Cancer
•Granzyme B - a potent payload for antibody drug conjugates (ADC)
•Antibody Fc engineering: aglycosylated antibodies with potent and
specific effector function
•Avicins, new class of triterpenes to treat cancer – IND approved
package
•Filaggrin to treat dermatological disorders
•RTEF therapy for ocular neovascular disease
•Vaccines and Diagnostics for Ehrlichioses
•Synergistic activation of beta-islet cell production
•CRFR1 and CRFR2 agonists for Diabetes
•CRFR1 antagonists - therapeutic for early onset AD
8
Please contact us!
Clayton Biotechnologies, Inc.
One Riverway, Suite 1520
Houston, Texas 77056
713.963.5860
www.claytonbiotech.com
[email protected]
9

similar documents